These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 7113673)

  • 1. Immune complexes in serum and cerebrospinal fluid of multiple sclerosis patients and patients with other neurological diseases.
    Salmi A; Ziola B; Reunanen M; Julkunen I; Wager O
    Acta Neurol Scand; 1982 Jul; 66(1):1-15. PubMed ID: 7113673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune complexes in CSF and serum in various neurological diseases.
    Cavalli M; Merelli E; Sola P; Pirrò G; Faglioni P
    Ital J Neurol Sci; 1986 Apr; 7(2):249-52. PubMed ID: 3721833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection and isolation of immune complexes in multiple sclerosis cerebrospinal fluid.
    Coyle PK
    J Neuroimmunol; 1987 May; 15(1):97-107. PubMed ID: 3571487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune complexes and the complement factors C4 and C3 in cerebrospinal fluid and serum from patients with chronic progressive multiple sclerosis.
    Jans H; Heltberg A; Zeeberg I; Kristensen JH; Fog T; Raun NE
    Acta Neurol Scand; 1984 Jan; 69(1):34-8. PubMed ID: 6702418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating immune complexes in patients with multiple sclerosis. A longitudinal study of serum and CSF by C1q and platelet binding tests.
    Arnadottir T; Kekomäki R; Lund GA; Reunanen M; Salmi AA
    J Neurol Sci; 1982 Sep; 55(3):273-83. PubMed ID: 6982312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of immune complexes in multiple sclerosis by an antigen-specific immune complex radioimmunoassay.
    Lund GA; Arnadottir T; Hukkanen V; Reunanen M; Salmi A
    J Neuroimmunol; 1983 Jun; 4(3):253-64. PubMed ID: 6853697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soluble immune complexes in cerebrospinal fluid of patients with multiple sclerosis and other neurological diseases.
    Glikmann G; Svehag SE; Hansen E; Hansen O; Husby S; Nielsen H; Farrell C
    Acta Neurol Scand; 1980 Jun; 61(6):333-43. PubMed ID: 6998248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNAs of Human Herpesvirus 6A and 6B in Serum and Cerebrospinal Fluid of Multiple Sclerosis Patients.
    Domínguez-Mozo MI; Nieto-Guerrero A; Pérez-Pérez S; García-Martínez MÁ; Arroyo R; Álvarez-Lafuente R
    Front Immunol; 2020; 11():2142. PubMed ID: 33072077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibodies to the axolemma-enriched fraction in the cerebrospinal fluid and serum of patients with multiple sclerosis and other neurological diseases.
    Rawes JA; Calabrese VP; Khan OA; DeVries GH
    Mult Scler; 1997 Dec; 3(6):363-9. PubMed ID: 9493635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soluble HLA class I and class II molecule levels in serum and cerebrospinal fluid of multiple sclerosis patients.
    Filaci G; Contini P; Brenci S; Gazzola P; Lanza L; Scudeletti M; Indiveri F; Mancardi GL; Puppo F
    Hum Immunol; 1997 Apr; 54(1):54-62. PubMed ID: 9154458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating immune complexes in serum and in cerebrospinal fluid of patients with multiple sclerosis. Characterization and correlation with the clinical course.
    Procaccia S; Lanzanova D; Caputo D; Ferrante P; Papini E; Gasparini A; Colucci A; Bianchi M; Villa P; Blasio R
    Acta Neurol Scand; 1988 May; 77(5):373-81. PubMed ID: 3046225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenotype analysis of unstimulated lymphocytes and anti-CD3-stimulated proliferating T-cells from cerebrospinal fluid and peripheral blood in patients with multiple sclerosis and other neurological diseases.
    Dufour A; Salmaggi A; Eoli M; La Mantia L; Milanese C; Nespolo A
    Int J Neurosci; 1993 Dec; 73(3-4):277-85. PubMed ID: 7513316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune Parameters That Distinguish Multiple Sclerosis Patients from Patients with Other Neurological Disorders at Presentation.
    Mouzaki A; Rodi M; Dimisianos N; Emmanuil A; Kalavrizioti D; Lagoudaki R; Grigoriadis NC; Papathanasopoulos P
    PLoS One; 2015; 10(8):e0135434. PubMed ID: 26317430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Binding properties of cerebrospinal fluid IgG in multiple sclerosis and other neurological diseases.
    Page N; Perruisseau G; Steck AJ
    J Neurol Sci; 1983 Jul; 60(1):23-30. PubMed ID: 6192219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of natural killer cell cytotoxicity by prostaglandin E in the peripheral blood and cerebrospinal fluid of patients with multiple sclerosis and other neurological diseases. Part 2. Effect of exogenous PGE1 on spontaneous and interferon-induced natural killer.
    Merrill JE; Myers LW; Ellison GW
    J Neuroimmunol; 1983 Jun; 4(3):239-51. PubMed ID: 6189856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the response to phytohemagglutinin, of peripheral blood mononuclear cells and cerebrospinal fluid lymphocytes in multiple sclerosis and other neurological diseases. Determination of the frequency of the precursor cells by a limiting dilution analysis.
    Tournier-Lasserve E; Roullet E; Lyoncaen O; Bach MA
    Acta Neurol Scand; 1986 Jul; 74(1):66-71. PubMed ID: 3490111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune surveillance in multiple sclerosis patients treated with natalizumab.
    Stüve O; Marra CM; Jerome KR; Cook L; Cravens PD; Cepok S; Frohman EM; Phillips JT; Arendt G; Hemmer B; Monson NL; Racke MK
    Ann Neurol; 2006 May; 59(5):743-7. PubMed ID: 16634029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The complex relationship between oligoclonal bands, lymphocytes in the cerebrospinal fluid, and immunoglobulin G antibodies in multiple sclerosis: Indication of serum contribution.
    Beseler C; Vollmer T; Graner M; Yu X
    PLoS One; 2017; 12(10):e0186842. PubMed ID: 29059249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sensitization of cerebrospinal fluid and peripheral blood lymphocytes to myelin basic protein in multiple sclerosis.
    Członkowska A; Półtorak M; Cendrowski W; Korlak J
    Acta Neurol Scand; 1982 Jul; 66(1):121-9. PubMed ID: 6180592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebrospinal fluid beta-2-microglobulin in multiple sclerosis and AIDS dementia complex.
    Carrieri PB; Indaco A; Maiorino A; Buscaino GA; Ponticiello A; Liberti A; Perrella O
    Neurol Res; 1992 Jun; 14(3):282-3. PubMed ID: 1355285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.